Dotinurad: all 22 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution TimeNot yet recruitingNCT07661030Phase 4
• A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsRecruitingNCT07535034Phase 2
• A Study of Dotinurad Versus Allopurinol in Tophaceous GoutRecruitingNCT07089888Phase 3
• A Study of Dotinurad Versus Allopurinol in Participants With GoutRecruitingNCT07089875Phase 3
• Effect of Dotinurad in Hyperuricemia With HypertensionRecruitingNCT06834230Phase 4
• Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With HyperuricemiaCompletedNCT06056570Phase 1/2Results posted
• A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With GoutCompletedNCT05007392Phase 3Results posted
• A Single and Multiple Dose Study of Dotinurad in Chinese Healthy ParticipantsCompletedNCT05278676Phase 1
• Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)CompletedNCT03375632Phase 1
• Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03372200Phase 3
• Drug-drug Interaction Study of FYU-981 and OxaprozinCompletedNCT03350386Phase 1
• Clinical Pharmacology of FYU-981 (Final Formulation)CompletedNCT03350373Phase 1
• Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)CompletedNCT03306667Phase 1
• Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03100318Phase 3
• Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT03006445Phase 3
• Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)CompletedNCT02515864Phase 2
• Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT02416167Phase 2
• Repeated Dose Phase I Study of FYU-981CompletedNCT02348333Phase 1
• Single Dose Phase I Study of FYU-981CompletedNCT02348307Phase 1
• Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)CompletedNCT02347046Phase 1
• Clinical Pharmacology of FYU-981 (Elder Subjects)CompletedNCT02344875Phase 1
• Study of FYU-981 in Hyperuricemia With or Without GoutCompletedNCT02344862Phase 2

← Dotinurad overview